Infervision, a Chinese startup that offers artificial intelligence (AI)-based medical imaging solutions, has closed a new investment that brings the firm’s total capital raise in its Series D round to nearly 900 million yuan ($139 million).
The investment is the second tranche of the Series D round, following the completion of its Series D1 round in November 2020. The startup did not disclose how much it raised respectively in the two tranches.
